NCT05871164 Longitudinal, Prospective, French, Multicenter Cohort Study on Pancreatic Radiofrequency
| NCT ID | NCT05871164 |
| Status | Recruiting |
| Phase | — |
| Sponsor | GCS Ramsay Santé pour l'Enseignement et la Recherche |
| Condition | Pancreatic Tumor |
| Study Type | OBSERVATIONAL |
| Enrollment | 200 participants |
| Start Date | 2023-06-12 |
| Primary Completion | 2030-05 |
Eligibility & Interventions
Eligibility Fast-Check
Enter your details for a quick preliminary check. This does not replace medical advice.
What to Expect as a Participant
This is an observational study. You will not receive an experimental treatment; researchers will collect data based on your existing condition or standard treatment.
This trial targets 200 participants in total. It began in 2023-06-12 with a primary completion date of 2030-05.
⚠ This information is for research awareness only. Always consult your physician before joining any clinical trial. Participation is voluntary and you may withdraw at any time.
Brief Summary
The purpose of the study is to evaluate the oncological efficacy of pancreatic radiofrequency by the objective response rate (complete and partial responses according to RECIST 1.1.), 5 years after the end of treatment.
Eligibility Criteria
Inclusion Criteria: * Age ≥ 18 years old; * Patient to be treated for a pancreatic tumor by ultrasound-guided RF with a fine needle; * Indication of pancreatic radiofrequency validated in a Multidisciplinary Consultation Meeting; * Patient able to understand the information related to the study; * Patient accepting study follow-up visits; * Patient having been informed and agreeing to participate in the study. Exclusion Criteria: * Patient with a contraindication to radiofrequency treatment; * Pregnant or breastfeeding women
Contact & Investigator
Frequently Asked Questions
Who can join the NCT05871164 clinical trial?
This trial is open to participants of all sexes, aged 18 Years or older, studying Pancreatic Tumor. Full inclusion and exclusion criteria are listed in the Eligibility Criteria section. Always confirm your eligibility with the research team before applying.
Is NCT05871164 currently recruiting?
Yes, NCT05871164 is actively recruiting participants. Contact the research team at dr.napoleon@wanadoo.fr for enrollment information.
Where is the NCT05871164 trial being conducted?
This trial is being conducted at Toulon, France.
Who is sponsoring the NCT05871164 clinical trial?
NCT05871164 is sponsored by GCS Ramsay Santé pour l'Enseignement et la Recherche. The trial plans to enroll 200 participants.